ANG Lifesciences opened higher at ₹39.85, compared with its previous close of ₹38.00. In the last trading session on 12 Nov 2026, the stock traded between ₹36.00 and ₹39.85, with an average traded price of ₹38.04. It showed a downward intraday trend.
An investment of ₹10,000 made 5 years ago in ANG Lifesciences is now worth
₹ 699.00
Resulting in a loss of
₹ 9,301.00 (93.01%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-1.45 (-3.82%)
Day High
₹39.85
Day Low
₹36.00
Day Open
₹39.85
Prev Close
₹38.00
Volume
7,794
Value Traded
₹0.03 Cr
1W Return
-1.91%
1M Return
0.58%
3M Return
15.45%
6M Return
33.69%
1Y Return
16.77%
Market Cap (₹ Cr.)
48
PE Ratio
-3.70
PB Ratio
1.03
Dividend Yield
2.63%
ROE
-20.96%
ROCE
-8.47%
Book Value (₹)
36.91
Face Value (₹)
10.00
EPS (TTM)
-3.24
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-1.91%
6 Weeks
-
1 Month
0.58%
3 Months
15.45%
9 Months
39.29%
Ang Lifesciences shareholders approve all AGM resolutions including director reappointment
All five resolutions at ANG Lifesciences' 20th AGM passed with requisite consent. Reappointment of Chetna as Independent Director approved with 99.78% votes in favor. Adoption of FY26 financial statements and Rohit Mittal's reappointment passed unanimously. Cost auditor remuneration ratification secured 99.78% shareholder support.
1mo agoANG Lifesciences fixes AGM date, approves director re-appointments
ANG Lifesciences fixes 20th AGM for September 30, 2026. Book closure runs from September 24 to September 30, 2026. Board approves re-appointment of Mr. Rohit Mittal by rotation. Mrs. Chetna re-appointed as Independent Director for five years.
2mo agoANG Lifesciences closes trading window ahead of Q1FY27 results
ANG Lifesciences India Ltd has closed its trading window for insiders and designated persons starting July 1, 2026, until 48 hours after the Q1FY27 results declaration. The move complies with SEBI regulations and the company's code of conduct. The date for the board meeting to consider the unaudited financial results for the quarter ended June 30, 2026, will be announced separately.
4mo agoANG Lifesciences narrows FY26 loss to ₹1,108 lakh
ANG Lifesciences India Limited reported a narrowed consolidated net loss of ₹1,108.48 lakh for FY26, with revenue from operations rising marginally to ₹9,289.28 lakh. The standalone net loss improved to ₹472.64 lakh. Statutory auditors M/s Khurana Sharma & Company issued an unmodified opinion but highlighted defaults on HDFC Bank borrowings totaling ₹1,344.16 lakh standalone and ₹2,586.45 lakh consolidated, alongside unpaid statutory dues exceeding six months. The company operates in Pharmaceuticals and Printing and Packaging segments.
5mo agoANG Lifesciences schedules board meeting on May 30
ANG Lifesciences India Limited will hold a board meeting on May 30, 2026, to approve the audited financial results for the quarter and fiscal year ending March 31, 2026. The trading window is currently closed and will reopen 48 hours after the results are announced.
5mo agoANG Lifesciences India Limited Confirms Non-Applicability of SEBI Large Corporate Borrowing Requirements for FY26
ANG Lifesciences India Limited has informed BSE that it does not qualify as a Large Corporate for FY26, making SEBI borrowing requirements and annual disclosure obligations non-applicable. The company referenced multiple regulatory circulars and committed to future compliance if it meets Large Corporate criteria.
7mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,898.30 | +0.71% | ₹4,55,465.76 | 41.20 | +9.60% | |
| ₹11,502.50 | +0.15% | ₹3,05,355.23 | 90.40 | +76.42% | |
| ₹4,689.50 | -0.80% | ₹1,78,373.51 | 85.50 | +22.61% | |
| ₹2,434.80 | +1.45% | ₹1,31,555.22 | 97.10 | +146.13% | |
| ₹1,204.60 | -0.12% | ₹1,20,159.31 | 28.00 | +26.61% | |
| ₹1,388.90 | +0.17% | ₹1,15,928.74 | 42.00 | +12.96% | |
| ₹1,409.30 | +0.07% | ₹1,13,851.49 | 39.90 | -7.24% | |
| ₹2,666.00 | +1.04% | ₹1,10,117.82 | 48.10 | +17.44% | |
| ₹1,816.20 | +0.50% | ₹1,04,500.13 | 26.00 | +53.45% | |
| ₹2,020.80 | +0.29% | ₹92,409.16 | 17.60 | -0.64% | |
| ₹2,641.50 | -0.69% | ₹74,549.65 | 51.60 | +42.95% | |
| ₹5,187.50 | -2.16% | ₹62,024.34 | 30.50 | -10.06% |
An investment of ₹10,000 made 5 years ago in ANG Lifesciences is now worth
₹ 699.00
Resulting in a loss of
₹ 9,301.00 (93.01%)
Note: Past profits do not guarantee future returns.
